e-learning
resources
ERS Research Seminars
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tyrosine Kinase Transmembrane Receptor alterations in NSCLC
Nicolas Girard (Lyon, France)
Source:
ERS Research Seminar
Number:
4
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicolas Girard (Lyon, France). Tyrosine Kinase Transmembrane Receptor alterations in NSCLC. ERS Research Seminar
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Kinase inhibitors
Source: Annual Congress 2012 - The promise of new drugs for treating asthma and COPD
Year: 2012
PI3 kinase Inhibition Reduces Uptake of Haemophilus Influenzae by Airway Epithelial Cells.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Hypoxia Promotes Human NSCLC Cell Line A549 Motility and EMT Through Extracellular HSP90a
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
TLR2 Promotes Allergic Airway Inflammation through JNK signaling pathway with Activation of Autophagy
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Late Breaking Abstract - Role of phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) in non-small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Deletion of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) Aggravates Pulmonary Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
LATE-BREAKING ABSTRACT: Protein tyrosine phosphatase (PTP)alpha promotes profibrotic responses in fibroblasts via Smad signaling
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Association of the Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 Genetic Polymorphisms with Non-small Cell Lung Cancer in Taiwan
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Immunity-6® Inhibits BEAS-2B and MRC-5 Cells Activation Induced by Sars-COV-2: Involvement with Purinergic Signaling
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Protein tyrosine phosphatase PTPRR regulates PP2A in mononuclear cells
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Mast Cell Tryptase Enhances Wound-Healing via Protease-Activated Receptor-2 Dependent Migration in Human Bronchial Epithelial Cells
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
The impact of ß-blockers in non–small cell lung cancer patients treated with Epidermal Growth Factor Receptor Kinase Inhibitors, Taiwan NHIRD database study.
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Distal Lung Epithelial Regeneration is Driven by Notch Pathway Inhibition and Enhanced by Ex Vivo Native Lung Scaffold Biomimetic Culture
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019
Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
Exosomes from Intermittent Hypoxia Treated Lung Adenocarcinoma Cell Line Up-regulate Programmed Death Ligand 1 Expression through HIF-1a Pathway in Macrophages
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept